HRCI-HRB Joint Funding Scheme 2020 – now openOctober 3, 2019
HRCI-HRB Joint Funding Scheme 2020 – now open content
Fighting Blindness is pleased to announce its participation in the Joint Funding Scheme 2020 between the Health Research Board and the Health Research Charities Ireland (formerly MRCG).
Our research priorities
Fighting Blindness is committed to the development of therapies that are accessible to all patients affected by sight loss and the wide spectrum of retinal degenerative disease through the pursuit and enablement of scientific medical research.
For this co-funding scheme, we are inviting original, internationally-competitive proposals that are relevant to the research priorities of Fighting Blindness and align with one or more of the following research areas:
- Elucidating molecular mechanisms and/or protective pathways in retinal degenerations
- Understanding genetic modifiers of retinal disease severity and progression
Cross-disciplinary collaborations that address a clinical need or current knowledge gaps are encouraged. Where applicable, projects must demonstrate a clear translational path to potential intervention.
The maximum funding available is €300,000 for 36 month project duration. However projects up to 12 months will also be considered.
|Thursday 31 Oct 2019 (5pm)||Submission of Expressions of Interest to Fighting Blindness|
|Friday 17 Jan 2020||Submission of full application (if shortlisted) to Fighting Blindness|
|Jan 2020||Fighting Blindness Peer Review|
|10 Feb – 28 Feb 2020||Right to reply|
|Monday 6 April 2020||HRB Application Deadline (via GEMs)|
|July 2020||Applicant Notification|
|November 2020||Project Start|
An initial Expressions of Interest (max 2-3 pages) should describe succinctly the following:
- Overall objectives of project
- Current knowledge and research gaps
- Relevance to goals of Fighting Blindness
- Implementation of Public and Patient Involvement
- Duration and Expected costs
Please submit an EOI to email@example.com by 5pm on Thursday 31 October 2019. Following review by our Medical and Scientific Advisory Board, a shortlist of successful applicants will be notified for requests for their full application.
For further information on the HRCI-HRB Joint Funding Scheme visit:
Or contact the research department via email on firstname.lastname@example.org